PSYCHEDELICS TO THERAPEUTICS Trademark

Trademark Overview

On Monday, November 1, 2021, a trademark application was filed for PSYCHEDELICS TO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PSYCHEDELICS TO THERAPEUTICS trademark a serial number of 97102763. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 25, 2025. This trademark is owned by Cybin Corp.. The PSYCHEDELICS TO THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
psychedelics to therapeutics

General Information

Serial Number97102763
Word MarkPSYCHEDELICS TO THERAPEUTICS
Filing DateMonday, November 1, 2021
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCybin Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1C9
CA

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 6, 2022EXAMINERS AMENDMENT -WRITTEN
Sunday, March 6, 2022EXAMINER'S AMENDMENT ENTERED
Monday, March 7, 2022SUSPENSION LETTER WRITTEN
Wednesday, September 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 14, 2022NON-FINAL ACTION WRITTEN
Sunday, March 6, 2022EXAMINERS AMENDMENT E-MAILED
Sunday, March 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 7, 2022LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, October 8, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 14, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 25, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, April 15, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, November 14, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Tuesday, March 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 14, 2024ASSIGNED TO LIE

Related Keywords

therapeutics psychedelics services development drug pharmaceutical